Found: 8
Select item for more details and to access through your institution.
Activation of peroxymonosulfate (PMS) by rGO supported Co<sub>3</sub>O<sub>4</sub> catalyst for iohexol degradation.
- Published in:
- Desalination & Water Treatment, 2024, v. 318, p. 1, doi. 10.1016/j.dwt.2024.100332
- By:
- Publication type:
- Article
Effects of Combined Exposure to Organophosphorus Flame Retardant TCPP and Lead on Zebrafish Development.
- Published in:
- Asian Journals of Ecotoxicology, 2024, v. 19, n. 1, p. 232, doi. 10.7524/AJE.1673-5897.20231017003
- By:
- Publication type:
- Article
Z‐Scheme Modulated Charge Transfer on InVO<sub>4</sub>@ZnIn<sub>2</sub>S<sub>4</sub> for Durable Overall Water Splitting.
- Published in:
- Small, 2023, v. 19, n. 19, p. 1, doi. 10.1002/smll.202207031
- By:
- Publication type:
- Article
A comparative study on adsorption behavior of iodinated X-ray contrast media iohexol and amidotrizoic acid by magnetic-activated carbon.
- Published in:
- Environmental Science & Pollution Research, 2022, v. 29, n. 30, p. 45404, doi. 10.1007/s11356-022-19127-9
- By:
- Publication type:
- Article
The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 5, p. 2247, doi. 10.1111/bcp.14646
- By:
- Publication type:
- Article
Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 1931, doi. 10.2147/DDDT.S303219
- By:
- Publication type:
- Article
Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01158
- By:
- Publication type:
- Article
Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 321, doi. 10.1007/s00228-018-2583-5
- By:
- Publication type:
- Article